Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bispecific Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06793813
What this trial is testing

Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Stage IVB Lung CancerNon-Squamous
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 44
Early research (Phase 1)Study completedNCT02221882
What this trial is testing

LY3164530 in Participants With Cancer

Who this might be right for
NeoplasmsNeoplasm Metastasis
Eli Lilly and Company 29
Testing effectiveness (Phase 2)Looking for participantsNCT06900010
What this trial is testing

Evaluate CM336 in Adults With Autoimmune Bullous Disease

Who this might be right for
Autoimmune Bullous Disease
Shandong First Medical University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07585760
What this trial is testing

CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment

Who this might be right for
Multiple Myeloma (MM)Multiple Myeloma Light Chain Induced Renal Insufficiency
Institute of Hematology & Blood Diseases Hospital, China 26
Early research (Phase 1)Looking for participantsNCT05544968
What this trial is testing

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Who this might be right for
Hodgkin DiseaseCD30-Positive Diffuse Large B-Cell LymphomaCD30+ Anaplastic Large Cell Lymphoma+4 more
Medical College of Wisconsin 42
Early research (Phase 1)Not Yet RecruitingNCT07234474
What this trial is testing

A Phase I Study of YK012 in Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Excyte Biopharma Ltd 66
Testing effectiveness (Phase 2)UnknownNCT02744768
What this trial is testing

D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 60
Not applicableNot Yet RecruitingNCT07614035
What this trial is testing

Identification of the Best Treatment Pathway for Patients With Relapsed/Refractory Lymphocytic B-derived Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT04626635
What this trial is testing

A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers

Who this might be right for
Advanced Solid Tumors
Regeneron Pharmaceuticals 548
Early research (Phase 1)Not Yet RecruitingNCT07763639
What this trial is testing

SI-B036 in Patients With Locally Advanced or Metastatic Head and Neck Tumors and Other Solid Tumors

Who this might be right for
Head and Neck TumorsSolid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)WithdrawnNCT03554395
What this trial is testing

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Fuda Cancer Hospital, Guangzhou
Not applicableLooking for participantsNCT07096349
What this trial is testing

Multidimensional Assessment of Chronic Pain in Severe Haemophilia A

Who this might be right for
Hemophilia A Without Inhibitor
Investigación en Hemofilia y Fisioterapia 109
Testing effectiveness (Phase 2)Study completedNCT04466891
What this trial is testing

ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers

Who this might be right for
HER2-amplified Biliary Tract Cancers
Jazz Pharmaceuticals 87
Not applicableStudy completedNCT05565391
What this trial is testing

Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 508
Testing effectiveness (Phase 2)Looking for participantsNCT06943820
What this trial is testing

AK129 Combination Therapy for Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer Stage IIIB/IVHead and Neck Squamous Cell Carcinoma (HNSCC)Colorectal Adenocarcinoma+1 more
Akeso 230
Early research (Phase 1)Looking for participantsNCT06826768
What this trial is testing

A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02912949
What this trial is testing

Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)

Who this might be right for
Solid Tumours Harboring NRG1 FusionNSCLC Harboring NRG1 FusionPancreatic Cancer Harboring NRG1 Fusion+1 more
Partner Therapeutics, Inc. 250
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686068
What this trial is testing

First-in-Human Trial of VBC106 in Participants With Advanced Solid Tumors

Who this might be right for
Participants With Advanced Solid Tumor Malignancies
VelaVigo Bio Inc 260
Post-approval studies (Phase 4)Looking for participantsNCT07609940
What this trial is testing

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05663866
What this trial is testing

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC 68
Next Page